Myriad Genetics (MYGN) EPS (Diluted) Growth (5y) (2014 - 2026)
Myriad Genetics (MYGN) EPS (Diluted) Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 296.09 Mn | 171.69 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.88% |
| Dec 31, 2025 | 34.54% |
| Sep 30, 2025 | 34.75% |
| Jun 30, 2025 | -9.32% |
| Mar 31, 2025 | 76.56% |
| Dec 31, 2024 | -33.28% |
| Sep 30, 2024 | 2.75% |
| Jun 30, 2024 | -48.24% |
| Mar 31, 2024 | -38.73% |
| Dec 31, 2023 | -67.25% |
| Sep 30, 2023 | -132.75% |
| Jun 30, 2023 | -55.38% |
| Mar 31, 2023 | -49.28% |
| Dec 31, 2022 | -26.36% |
| Sep 30, 2022 | -19.03% |
| Jun 30, 2022 | -24.55% |
| Mar 31, 2022 | -52.48% |
| Dec 31, 2021 | -25.32% |
| Sep 30, 2021 | 99.58% |
| Jun 30, 2021 | 48.91% |